ArticleBiomedicines2021

Concomitant High Apoptosis Inhibitor of Macrophage (AIM) and Low Prostate-Specific Antigen (PSA) Indicates Activated T Cell-Mediated Anticancer Immunity, Enhance Sensitivity to Pembrolizumab, and Elicit Good Prognosis in Prostate Cancer.

Oluwaseun Adebayo Bamodu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.